PepGen Presents Clinical and Nonclinical Data at the 2023 Annual Muscular Dystrophy Association Clinical and Scientific Conference

2 years ago

- In NHP, four monthly doses of 20 mg/kg of PGN-EDO51 resulted in 34.9% exon skipped transcripts in biceps; a…

VYNE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammation Disease Virtual Conference

2 years ago

BRIDGEWATER, N.J., March 22, 2023 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical…

Indaptus Therapeutics to Present at the Investor Summit Conference

2 years ago

NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and…

LifeMD, Inc. Announces Closing of New $40 Million Credit Facility

2 years ago

NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that…

Vanqua Bio to Present at the Stifel 2023 CNS Day Conference

2 years ago

CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Vanqua Bio, a biopharmaceutical company focused on discovering and developing next-generation medicines that…

Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development

2 years ago

Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial ExecutionMORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos…

DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product

2 years ago

Former Reliq Health Technologies Chief Innovation Officer and veteran product leader brings over a decade of experience building and commercializing…

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

2 years ago

Achieved clinical validation of PRISM platform in 2022 – demonstrated ability to potently and durably engage RNA targets and translate…

OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time

2 years ago

ROCKVILLE, Md., March 22, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the…

InflaRx Reports Full Year 2022 Financial and Operating Results

2 years ago

Major progress in development of vilobelimab Phase III study in PG announced following detailed feedback and recommendations from the U.S.…